logo-loader
CNSX:LXX

Lexaria Bioscience Corp

Receive alerts
Market:
CNSX
Market Cap:
$74.71 m
Price
$0.95
Change
1.06%
52 weeks high
2.80
52 weeks low
0.83

Filter by article type

Viewing results 1-25 of 51

Nano caps

NA Proactive news snapshot: BevCanna Enterprises, VolitionRx, Arizona Silver Exploration, GlobeX Data - UPDATE ...

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires...

17 hours, 35 minutes ago
Health

Lexaria Bioscience's DehydraTECH technology earns spot in medical journal with promising human CBD study results

The results showed that CBD doses delivered using DehydraTECH led to higher levels of concentration than generic doses...

18 hours, 13 minutes ago
Retail & consumer

Hill Street Beverage CEO to spotlight cannabis-infused beverages at investor summit in New York

Hill Street has acquired two global semi-exclusive licenses to utilize Lexaria Bioscience’s DehydraTECH THC and CBD beverage infusion technologies for 10 years...

5 days, 23 hours ago
Health

Lexaria Bioscience picks up new patent for DehydraTECH drug delivery technology

The new patent brings the biotechnology company's total to 16 across the US and Australia...

3 weeks, 1 day ago
Health

Lexaria Bioscience kicks off the commercial launch of its ChrgD+ water-soluble powdered hemp oil

The biotechnology company has used its drug delivery system DehydraTECH, to ensure that CBD enters the bloodstream within minutes ...

3 weeks, 6 days ago
Health

Buds & Duds: Cannabis stocks slump Thursday but Empower Clinics shares jump on promising 2Q results

Also on the move were BevCanna Enterprises, Lexaria, Canopy Growth and Tilray ...

on 08/15/2019
Health

Lexaria Bioscience picks up patents in the US and Australia for its DehydraTECH technology

The patents, two in the US and two in Australia, bring Lexaria’s total to 15 granted patents, along with 60 pending applications around the world...

on 08/15/2019
Health

Lexaria Bioscience taps a former Altria Group executive to join its board of directors

Brian Quigley, a 16-year veteren of Lexaria investor Altria Group, is joining the company's board...

on 08/14/2019
Health

Lexaria Bioscience secures cannabis R&D license from Health Canada

The license for the company’s new formulation lab will allow it to produce creams, lotions and focus on delivery of THC and CBD...

on 08/13/2019
Health

Lexaria Bioscience reveals exciting new findings from DehyraTECH study

The company collaborated with the National Research Council of Canada to examine new formulations of Lexaria's delivery platform technology...

on 08/08/2019
Health

Lexaria Bioscience hires Integra Consulting for investor relations services

Integra will work with the firm to communicate its message to maximize corporate visibility, seek out opportunities to deliver audience-targeted presentations, and will use web-casting to reach bigger audiences...

on 08/02/2019
Health

Lexaria Bioscience trumpets its slate of DehydraTECH licensing agreements

The company has 9 corporate licensees with 11 licenses developing unique products using its absorption technology...

on 07/30/2019
Health

Lexaria Bioscience, Hill Street Beverage sign 10-year joint manufacturing partnership for DehydraTech products

Under the partnership, both Canadian companies will jointly produce Lexaria's DehydraTech products, including THC and CBD powder...

on 07/24/2019
Health

Lexaria Bioscience is seeing increased demand for its DehydraTECH drug delivery system

DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform...

on 07/12/2019
Health

Lexaria Bioscience inks CBD license pact in US and Canada with Universal Hemp

CEO Chris Bunka says the arrangement will enable the company’s patented technology to have widespread use in ‘high-performance products’ providing precision dosing...

on 07/11/2019
Health

Lexaria Bioscience inks CBD beverage license agreement in US with Nic's Beverages

Nic's Beverages CEO John Goodpasture says DehydraTECH technology is 'perfect' for allowing the delivery of CBD from hemp oil with 'zero impact' on the company's cold brewed coffee's flavor...

on 07/10/2019
Health

Buds & Duds: Cannabis stocks continue to slump but Lexaria Bioscience shares shine on CBD beverage deal

Also on the move were Martello Technologies, CannTrust and TILT Holdings...

on 07/10/2019
Health

Lexaria Bioscience springs for digital marketing services from the Richmond Club

The company will help Lexaria with investor presentations, articles and videos, and other digital marketing services...

on 07/05/2019
Health

Lexaria Bioscience shareholders approve the appointment of four directors

Shareholders approved all matters at the annual general meeting, including the appointment of Davidson & Company LLP as auditor...

on 06/21/2019
Health

Lexaria Bioscience crafts new DehydraTECH innovation, files patents

New enhanced DehydraTECH formulation delivers 8X more CBD into blood and over 19X more CBD into brain tissue than standard formulations...

on 06/04/2019